Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Effecty vs Gala Health

By GLP-1 ScorecardUpdated

Effecty
Site position #21

Higher grade

Gala Health
Site position #12

Lower grade

Score comparison

Effecty has the higher recorded score — 83.7/100 to 82.9/100, but only just.

Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-market pricing offset by brand-name access and LegitScript verification, all 50 states. Gala Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueGala Health +4
80
84
Dose & formulationEffecty +1
84
83
Clinical oversightEven
85
85
Labs & monitoringEffecty +1
84
83
FulfillmentGala Health +1
87
88
Contract termsEffecty +20
86
66
Effecty · top barGala Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEffectyGala Health
WeighScore83.7/10082.9/100
GradeBB−
Site position#21#12
Semaglutide$160/moFrom $129/mo (campaign; plan pages conflict—confirm billing term)
Tirzepatide$240/moFrom $179/mo (campaign; yearly and three-month offers conflict—confirm term)
CoverageAll 50 statesCoverage wording differs: all 50 on homepage, most U.S. states in campaign
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Effecty

Site position #21 · B

Strengths

  • Brand-name access
  • LegitScript-verified, all 50 states
  • Both molecules

What to consider

  • Higher pricing ($160/$240)
  • Injection-only
  • Not a value leader
Gala Health

Site position #12 · B−

Strengths

  • Campaign advertises $129 semaglutide and $179 tirzepatide with medication and telehealth visits included if prescribed
  • Brand-name Ozempic path and broader menopause/HRT services listed
  • Terms identify clinical practice networks; actual clinician and pharmacy assignment still need checking

What to consider

  • Yearly, three-month and no-contract campaign presentations differ; do not assume an annual upfront charge or flat month-to-month terms
  • Cancel at least 72 hours before renewal; ordinary cancellation does not produce a refund
  • Medical-disqualification refund wording differs between full-refund and remaining/current-cycle provisions
  • Dispensing pharmacy not identified for an individual order; oral option is a waitlist, not a current offer

Featured provider

Gala Health

Gala Health scores 82.9/100 (B−). Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard